April 28 (Reuters) - Roche Holding AG ROG.S :
* ROCHE CANADA - HEALTH CANADA APPROVES ROZLYTREK (ENTRECTINIB) FOR NTRK GENE FUSION-POSITIVE SOLID TUMOURS IN LOCALLY ADVANCED OR METASTATIC PATIENTS
* ROCHE CANADA - ON FEB 10, 2020, HEALTH CANADA, UNDER NOTICE OF COMPLIANCE WITH CONDITIONS (NOC/C) POLICY, APPROVED ROZLYTREK (ENTRECTINIB)